Inhaltspezifische Aktionen



Klingenberg R, Holtkamp F, Grün D, Frey A, Jahns V, Jahns R, Gassenmaier T, Hamm CW, Frantz S, Keller T.

Use of serial changes in biomarkers vs. baseline levels to predict left ventricular remodelling after STEMI

ESC Heart Fail. 2022. ePub Oct 21.


Rieth AJ, Rivinius R, Lühring T, Grün D, Keller T, Grinninger C, Schüttler D, Bara CL, Helmschrott M, Frey N, Sandhaus T, Schulze C, Kriechbaum S, Vietheer J, Sindermann J, Welp H, Lichtenberg A, Choi YH, Richter M, Tello K, Richter MJ, Hamm CW, Boeken U.

Hemodynamic markers of pulmonary vasculopathy for prediction of early right heart failure and mortality after heart transplantation.

J Heart Lung Transplant. 2022. ePub 9 October 2022.


Kriechbaum SD, Birmes J, Wiedenroth CB, Adameit MSD, Gruen D, Vietheer J, Richter MJ, Guth S, Roller FC, Rademann M, Fischer-Rasokat U, Rolf A, Liebetrau C, Hamm CW, Keller T*, Rieth AJ*.

Exercise MR-proANP unmasks latent right heart failure in CTEPH.

J Heart Lung Transplant. 2022:S1053-2498(22)02084-8.

* contributed equally


Rieth AJ, Grün D, Zarogiannis G, Kriechbaum SD, Wolter S, Richter MJ, Tello K, Krüger U, Mitrovic V, Rosenkranz S, Hamm CW and Keller T.

Prognostic Power of Pulmonary Arterial Compliance is Boosted by a Hemodynamic Unloading Test with Glyceryl Trinitrate in Heart Failure Patients with Post-capillary Pulmonary Hypertension.

Frontiers in Cardiovascular Medicine. 2022. ePub 11 March 2022.

Keranov S, Jafari L, Haen S, Vietheer J, Kriechbaum S, Dörr O, Liebetrau C, Troidl C, Rutsatz W, Rieth A, Hamm CW, Nef H, Rolf A, Keller T.

CILP1 as a biomarker for right ventricular dysfunction in patients with ischemic cardiomyopathy.

Pulmonary Circulation. 2022. ePub 11 March 2022.


Guckert M, Milanovic K, Hannig J, Simon D, Wettengl T, Evers D, Kleyer A, Keller T, Pitt J.

The Disruption of Trust in the Digital Transformation Leading to Health 4.0.

Frontiers in Digital Health. 2022. ePub 28 Feb 2022.


Vietheer J, Lehmann L, Unbehaun C, Fischer-Rasokat U, Wolter JS, Kriechbaum S, Weferling M, von Jeinsen B, Hain A, Liebetrau C, Hamm CW, Keller T, Rolf A.

CMR-derived myocardial strain analysis differentiates ischemic and dilated cardiomyopathy—a propensity score-matched study

Int J Cardiovasc Imaging. 2021. ePub ahead of print 28 Nov 2021.


Keranov S., Haen S., Vietheer J., Rutsatz W., Wolter J.S., Kriechbaum S.D., von Jeinsen B., Bauer P., Tello K., Richter M., Dörr O., Rieth A.J., Nef H., Hamm C.W., Liebetrau C., Rolf A., Keller T.

Application and Validation of the Tricuspid Annular Plane Systolic Excursion/Systolic Pulmonary Artery Pressure Ratio in Patients with Ischemic and Non-Ischemic Cardiomyopathy

Diagnostics. 2021. 11(12), 2188


Kriechbaum S.D., Vietheer J.M., Wiedenroth C.B., Rudolph F., Barde M., Wolter J.S., Haas M., Fischer-Rasokat U., Weferling M., Rolf A., Hamm C.W., Mayer E., Guth S., Keller T., Roller F.C., Liebetrau C.

Cardiac biomarkers as indicators of right ventricular dysfunction and recovery in CTEPH patients after BPA therapy – a cardiac magnetic resonance imaging cohort study

Pulmonary Circulation. 2021. ePub ahead of print 22 Oct 2021.

Askari N., Lipps C., Voss S., Staubach N., Grün D., Klingenberg R., von Jeinsen B., Wolter J.S., Kriechbaum S., Dörr O., Nef H., Liebetrau C., Hamm C., Keller T.

Circulating Monocyte Subsets are Associated With Extent of Myocardial Injury but not With Type of Myocardial Infarction

Frontiers in Cardiovascular Medicine. 2021. 8:741890. 02 Nov 2021


Haller P.M., Neumann J.T., Sörensen N.A., Hartikainen T.S., Goßling A., Lehmacher J., Keller T., Zeller T., Blankenberg S., Westermann D.

The association of anaemia and high-sensitivity cardiac troponin and its effect on diagnosing myocardial infarction.

Eur Heart J Acute Cardiovasc Care. 2021; ePub ahead of print 04 August 2021.


Tzikas S., Boulmpou A., Bakogiannis C., Evangeliou A.P., Papadopoulos C.E., Vassilikos V., Zafeiropoulos S., Hamilos M., Noutsias M., Tsigkas G., Kanakakis I., Keller T.

A proposal for implementation of the chest pain unit model in Greece

Hellenic Journal of Cardiology. 2021; 62(4):304-305


Gumpfer N., Prim J., Grün D., Hannig J., Keller T., Guckert M.

An Experiment Environment for Definition, Training and Evaluation of Electrocardiogram-Based AI Models.

Artificial Intelligence in Medicine (AIME) 2021. Lecture Notes in Computer Science (LNCS), vol 12721.


Weferling M., Liebetrau C., Kraus D., Zierentz P., von Jeinsen B., Dörr O., Weber M., Nef H., Hamm C.W., Keller T.

Definition of acute kidney injury impacts prevalence and prognosis in ACS patients undergoing coronary angiography.

BMC Cardiovascular Disorders. 2021;21:183.


Guckert M., Gumpfer N., Hannig J., Keller T., Urquhart N.

A Conceptual Framework for Establishing Trust in Real World Intelligent Systems.

Cognitive Systems Research. 2021; ePub ahead of print 28 April 2021.


Keranov S., Dörr O., Jafari L., Troidl C., Liebetrau C., Kriechbaum S., Keller T., Voss S., Bauer T., Lorenz J., Richter M.J., Tello K., Gall H., Ghofrani H.A., Mayer E., Wiedenroth C.B., Guth S., Lörchner H., Pöling J., Chelladurai P., Pullamsetti S.S., Braun T., Seeger W., Hamm C.W., Nef H.

CILP1 as a biomarker for right ventricular maladaptation in pulmonary hypertension.

Eur Respir J. 2021;57(4):1901192.


Weferling M., Vietheer J., Keller T., Fischer-Rasokat U., Hamm C.W., Liebetrau C.

Association Between Primary Coronary Slow-Flow Phenomenon and Epicardial Fat Tissue.

J Invasive Cardiol. 2021;33(1):E59-E64.


Grün D.,  Rudolph F.,  Gumpfer N.,  Hannig J., Elsner L., von Jeinsen B., Hamm C., Rieth A., Guckert M., Keller T.

Identifying Heart Failure in ECG Data with Artificial Intelligence - a Meta-Analysis

Front Digit Health. 2021;2:584555.


Kriechbaum SD, Wiedenroth CB, Peters K, Barde MA, Ajnwojner R, Wolter JS, Haas M, Roller FC, Guth S, Rieth AJ, Rolf A, Hamm CW, Mayer E, Keller T, Liebetrau C.

Galectin-3, GDF-15, and sST2 for the assessment of disease severity and therapy response in patients suffering from inoperable chronic thromboembolic pulmonary hypertension

Biomarkers. 2020;25(7):578-586.


Bormann J., Psyrakis D.A., von Jeinsen B., Grün D., Elsner L.K., Wolter J.S., Weferling M., Diouf K., Kriechbaum S., Troidl C., Dörr O., Nef H., Hamm C.W., Liebetrau C., Keller T.

Myeloid-related protein 8/14 and high-sensitivity cardiac troponin I to differentiate type 2 myocardial infarction.

Int J Cardiol. 2020;304:144-147.


Arcari L., Hinojar R., Engel J., Freiwald T., Platschek S., Zainal H., Zhou H., Vasquez M., Keller T., Rolf A., Geiger H., Hauser I., Vogl T.J., Zeiher A.M., Volpe M., Nagel E., Puntmann V.O.

Native T1 and T2 provide distinctive signatures in hypertrophic cardiac conditions - Comparison of uremic, hypertensive and hypertrophic cardiomyopathy.

Int J Cardiol. 2020;306:102-108.


Elsner L.K., Jeinsen B.v., Grün D., Wolter J.S., Weferling M., Diouf K., Kriechbaum S., Troidl C., Dörr O., Nef H., Hamm C.W., Liebetrau C., Keller T.

Prognostic performance of the ESC SCORE and its German recalibrated versions in primary and secondary prevention.

Eur J Prev Cardiol. 2020;27(19):2166-2169.


Gumpfer N., Grün D., Hannig J., Keller T., Guckert M.

Detecting myocardial scar using electrocardiogram data and deep neural networks.

Biol Chem. 2020; Online ahead of print.


Haller P.M., Boeddinghaus J., Neumann J.T., Sörensen N.A., Hartikainen T.S., Goßling A., Nestelberger T., Twerenbold R., Lehmacher J., Keller T., Zeller T., Blankenberg S., Mueller C., Westermann D.

Performance of the ESC 0/1-h and 0/3-h Algorithm for the Rapid Identification of Myocardial Infarction Without ST-Elevation in Patients With Diabetes.

Diabetes Care. 2020;43(2):460-467.


Kriechbaum S.D., Rudolph F., Wiedenroth C.B., Mielzarek L., Haas M., Guth S., Hamm C.W., Mayer E., Liebetrau C., Keller T.

Pregnancy-associated plasma protein A - a new indicator of pulmonary vascular remodeling in chronic thromboembolic pulmonary hypertension?

Resp Res. 2020;21(1):204.


Kriechbaum S.D., Scherwitz L., Wiedenroth C.B., Rudolph F., Wolter J.S., Haas M., Fischer-Rasokat U., Rolf A., Hamm C.W., Mayer E., Guth S., Keller T., Konstantinides S.V., Lankeit M., Liebetrau C.

Mid-regional pro-atrial natriuretic peptide and copeptin as indicators of disease severity and therapy response in CTEPH.

ERJ Open Res. 2020;6(4):00356-2020.


Rieth A.J., Hamm C.W., Wanner C., Mitrovic V., Keller T.

[Heart failure protection by SGLT2 inhibitors in patients with type 2 diabetes mellitus: evidence and possible mechanisms: A systematic review].

HERZ. 2020; Online ahead of print.


von Jeinsen B., Ritzen L., Vietheer J., Unbehaun C., Weferling M., Liebetrau C., Hamm C.W., Rolf A., Keller T.

The adipokine fatty-acid binding protein 4 and cardiac remodeling.

Cardiovasc Diabetol. 2020; 19(1): 117.





Diouf K., Elsner L., Rohr M., Wolter J.S., Dörr O., Hamm C.W., Liebetrau C., Keller T.

Anti-citrullinated protein antibodies are not associated with extent of disease or prognosis in patients with coronary artery disease.

Clin Chem Lab Med. 2019;57(7):e159-e161.


Neumann J.T., Twerenbold R., Ojeda F., Sörensen N.A., Chapman A.R., Shah A.S.V., Anand A., Boeddinghaus J., Nestelberger T., Badertscher P., Mokhtari A., Pickering J.W., Troughton R.W., Greenslade J., Parsonage W., Mueller-Hennessen M., Gori T., Jernberg T., Morris N., Liebetrau C., Hamm C., Katus H.A., Münzel T., Landmesser U., Salomaa V., Iacoviello L., Ferrario M.M., Giampaoli S., Kee F., Thorand B., Peters A., Borchini R., Jørgensen T., Söderberg S., Sans S., Tunstall-Pedoe H., Kuulasmaa K., Renné T., Lackner K.J., Worster A., Body R., Ekelund U., Kavsak P.A., Keller T., Lindahl B., Wild P., Giannitsis E., Than M., Cullen L.A., Mills N.L., Mueller C., Zeller T., Westermann D., Blankenberg S.

Application of High-Sensitivity Troponin in Suspected Myocardial Infarction.

New Engl L Med. 2019;380(26):2529-2540.


von Jeinsen B., Sopova K., Palapies L., Leistner D.M., Fichtlscherer S., Seeger F.H., Honold J., Dimmeler S., Aßmus B., Zeiher A.M., Keller T.

Bone marrow and plasma FGF-23 in heart failure patients: novel insights into the heart-bone axis.

ESC Heart Fail. 2019;6(3): 536-544.


Kriechbaum S.D., Wiedenroth C.B., Hesse M.L., Ajnwojner R., Keller T., Sebastian Wolter J., Haas M., Roller F.C., Breithecker A., Rieth A.J., Guth S., Rolf A., Hamm C.W., Mayer E., Liebetrau C.

Development of renal function during staged balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension.

Scand J clin Lab Inv. 2019;79(4): 268-275.


von Jeinsen V. and Keller T.

[Troponinwerte und der akute Myokardinfarkt - Ein Update mit Fokus auf Infarkttypen und Myokardschädigung]

Der Klinikarzt. 2019;48(04):129-133


Tzikas S., Vassilikos V., Keller T.

GDF-15 as a risk stratification biomarker for cardiovascular disease.

Int J Cardiol 2019. 292: 246-247.


Keller T. and Hamm C.W.

High-sensitivity cardiac troponin assays: finally ready for prime time?

Nat Rev Cardiol 2019. 16(3): 135-136.


Boeckel J.N., Perret M.F., Glaser S.F., Seeger T., Heumüller A.W., Chen W., John D., Kokot K.E., Katus H.A., Haas J., Lackner M.K., Kayvanpour E., Grabe N., Dieterich C., von Haehling S., Ebner N., Hünecke S., Leuschner F., Fichtlscherer S., Meder B., Zeiher A.M., Dimmeler S., Keller T.

Identification and regulation of the long non-coding RNA Heat2 in heart failure.

J Mol Cell Cardiol. 2019 126: 13-22.


von Jeinsen B., Liebetrau C., Palapies L., Tzikas S., Zeller T., Bickel C., Schmidt A., Tubaro M., Lackner K.J., Sar F., Baldus S., Zeiher A.M., Blankenberg S., Gori T., Münzel T., Hamm C.W., Wild P.S., Keller T.

Identification of acute myocardial infarction in elderly patients using optimized highly sensitive troponin I thresholds.

Biomarkers 2019. 24(6): 549-555.


Bauer P., Kraushaar L., Most A., Hölscher S., Tajmiri-Gondai S., Dörr O., Troidl C., Bauer T., Nef H., Hamm C.W., Keller T.

Impact of Vascular Function on Maximum Power Output in Elite Handball Athletes.

Res Q Exercise Sport 2019. 90(4): 600-608.


Lipps C., Northe P., Figueiredo R., Rohde M., Brahmer A., Krämer-Albers E.M., Liebetrau C., Wiedenroth C.B., Mayer E., Kriechbaum S.D., Dörr O., Nef H., Hamm C.W., Keller T., Troidl C.

Non-Invasive Approach for Evaluation of Pulmonary Hypertension Using Extracellular Vesicle-Associated Small Non-Coding RNA.

Biomolecules 2019. 9(11): 1-16.


Sörensen N.A., Ludwig S., Makarova N., Neumann J.T., Lehmacher J., Hartikainen T.S., Haller P.M., Keller T., Blankenberg S., Westermann D., Zeller T., Schofer N.

Prognostic Value of a Novel and Established High-Sensitivity Troponin I Assay in Patients Presenting with Suspected Myocardial Infarction.

Biomolecules 2019. 9(9): 469.


Neumann J.T., Sörensen N.A., Rübsamen N., Ojeda F., Schäfer S., Keller T., Blankenberg S., Clemmensen P., Westermann D.

Right bundle branch block in patients with suspected myocardial infarction.

Eur Heart J - Acute CA 2019. 8(2): 161-166.